Cargando…

Ethanolic Extract of Centella asiatica Treatment in the Early Stage of Hyperglycemia Condition Inhibits Glomerular Injury and Vascular Remodeling in Diabetic Rat Model

BACKGROUND: Diabetes mellitus (DM) is marked by oxidative stress, inflammation, and vascular dysfunction that caused diabetic nephropathy that resulted in end-stage renal disease (ESRD). Vascular dysfunction is characterized by an imbalance in vasoconstrictor and vasodilator agents which underlies t...

Descripción completa

Detalles Bibliográficos
Autores principales: Setyaningsih, Wiwit A. W., Arfian, Nur, Fitriawan, Akbar S., Yuniartha, Ratih, Sari, Dwi C. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277496/
https://www.ncbi.nlm.nih.gov/pubmed/34326888
http://dx.doi.org/10.1155/2021/6671130
_version_ 1783722084675878912
author Setyaningsih, Wiwit A. W.
Arfian, Nur
Fitriawan, Akbar S.
Yuniartha, Ratih
Sari, Dwi C. R.
author_facet Setyaningsih, Wiwit A. W.
Arfian, Nur
Fitriawan, Akbar S.
Yuniartha, Ratih
Sari, Dwi C. R.
author_sort Setyaningsih, Wiwit A. W.
collection PubMed
description BACKGROUND: Diabetes mellitus (DM) is marked by oxidative stress, inflammation, and vascular dysfunction that caused diabetic nephropathy that resulted in end-stage renal disease (ESRD). Vascular dysfunction is characterized by an imbalance in vasoconstrictor and vasodilator agents which underlies the mechanism of vascular injury in DM. Additionally, diminished podocytes correlate with the severity of kidney injury. Podocyturia often precedes proteinuria in several kidney diseases, including diabetic kidney disease. Centella asiatica (CeA) is known as an anti-inflammatory and antioxidant and has neuroprotective effects. This research aimed to investigate the potential effect of CeA to inhibit glomerular injury and vascular remodeling in DM. METHODS: The DM rat model was induced through intraperitoneal injection of streptozotocin 60 mg/kg body weight (BW), and then rats were divided into 1-month DM (DM1, n = 5), 2-month DM (DM2, n = 5), early DM concurrent with CeA treatment for 2 months (DMC2, n = 5), and 1-month DM treated with CeA for 1-month (DM1C1, n = 5). The CeA (400 mg/kg BW) was given daily via oral gavage. The control group (Control, n = 5) was maintained for 2 months. Finally, rats were euthanized and kidneys were harvested to assess vascular remodeling using Sirius Red staining and the mRNA expression of superoxide dismutase, podocytes marker, ACE2, eNOS, and ppET-1 using RT-PCR. RESULTS: The DM groups demonstrated significant elevation of glucose level, glomerulosclerosis, and proteinuria. A significant reduction of SOD1 and SOD3 promotes the downregulation of nephrin and upregulation of TRPC6 mRNA expressions in rat glomerular kidney. Besides, this condition enhanced ppET-1 and inhibited eNOS and ACE2 mRNA expressions that lead to the development of vascular remodeling marked by an increase of wall thickness, and lumen wall area ratio (LWAR). Treatment of CeA, especially the DMC2 group, attenuated glomerular injury and showed the reversal of induced conditions. CONCLUSIONS: Centella asiatica treatment at the early stage of diabetes mellitus ameliorates glomerulosclerosis and vascular injury via increasing antioxidant enzymes.
format Online
Article
Text
id pubmed-8277496
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-82774962021-07-28 Ethanolic Extract of Centella asiatica Treatment in the Early Stage of Hyperglycemia Condition Inhibits Glomerular Injury and Vascular Remodeling in Diabetic Rat Model Setyaningsih, Wiwit A. W. Arfian, Nur Fitriawan, Akbar S. Yuniartha, Ratih Sari, Dwi C. R. Evid Based Complement Alternat Med Research Article BACKGROUND: Diabetes mellitus (DM) is marked by oxidative stress, inflammation, and vascular dysfunction that caused diabetic nephropathy that resulted in end-stage renal disease (ESRD). Vascular dysfunction is characterized by an imbalance in vasoconstrictor and vasodilator agents which underlies the mechanism of vascular injury in DM. Additionally, diminished podocytes correlate with the severity of kidney injury. Podocyturia often precedes proteinuria in several kidney diseases, including diabetic kidney disease. Centella asiatica (CeA) is known as an anti-inflammatory and antioxidant and has neuroprotective effects. This research aimed to investigate the potential effect of CeA to inhibit glomerular injury and vascular remodeling in DM. METHODS: The DM rat model was induced through intraperitoneal injection of streptozotocin 60 mg/kg body weight (BW), and then rats were divided into 1-month DM (DM1, n = 5), 2-month DM (DM2, n = 5), early DM concurrent with CeA treatment for 2 months (DMC2, n = 5), and 1-month DM treated with CeA for 1-month (DM1C1, n = 5). The CeA (400 mg/kg BW) was given daily via oral gavage. The control group (Control, n = 5) was maintained for 2 months. Finally, rats were euthanized and kidneys were harvested to assess vascular remodeling using Sirius Red staining and the mRNA expression of superoxide dismutase, podocytes marker, ACE2, eNOS, and ppET-1 using RT-PCR. RESULTS: The DM groups demonstrated significant elevation of glucose level, glomerulosclerosis, and proteinuria. A significant reduction of SOD1 and SOD3 promotes the downregulation of nephrin and upregulation of TRPC6 mRNA expressions in rat glomerular kidney. Besides, this condition enhanced ppET-1 and inhibited eNOS and ACE2 mRNA expressions that lead to the development of vascular remodeling marked by an increase of wall thickness, and lumen wall area ratio (LWAR). Treatment of CeA, especially the DMC2 group, attenuated glomerular injury and showed the reversal of induced conditions. CONCLUSIONS: Centella asiatica treatment at the early stage of diabetes mellitus ameliorates glomerulosclerosis and vascular injury via increasing antioxidant enzymes. Hindawi 2021-07-06 /pmc/articles/PMC8277496/ /pubmed/34326888 http://dx.doi.org/10.1155/2021/6671130 Text en Copyright © 2021 Wiwit A. W. Setyaningsih et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Setyaningsih, Wiwit A. W.
Arfian, Nur
Fitriawan, Akbar S.
Yuniartha, Ratih
Sari, Dwi C. R.
Ethanolic Extract of Centella asiatica Treatment in the Early Stage of Hyperglycemia Condition Inhibits Glomerular Injury and Vascular Remodeling in Diabetic Rat Model
title Ethanolic Extract of Centella asiatica Treatment in the Early Stage of Hyperglycemia Condition Inhibits Glomerular Injury and Vascular Remodeling in Diabetic Rat Model
title_full Ethanolic Extract of Centella asiatica Treatment in the Early Stage of Hyperglycemia Condition Inhibits Glomerular Injury and Vascular Remodeling in Diabetic Rat Model
title_fullStr Ethanolic Extract of Centella asiatica Treatment in the Early Stage of Hyperglycemia Condition Inhibits Glomerular Injury and Vascular Remodeling in Diabetic Rat Model
title_full_unstemmed Ethanolic Extract of Centella asiatica Treatment in the Early Stage of Hyperglycemia Condition Inhibits Glomerular Injury and Vascular Remodeling in Diabetic Rat Model
title_short Ethanolic Extract of Centella asiatica Treatment in the Early Stage of Hyperglycemia Condition Inhibits Glomerular Injury and Vascular Remodeling in Diabetic Rat Model
title_sort ethanolic extract of centella asiatica treatment in the early stage of hyperglycemia condition inhibits glomerular injury and vascular remodeling in diabetic rat model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277496/
https://www.ncbi.nlm.nih.gov/pubmed/34326888
http://dx.doi.org/10.1155/2021/6671130
work_keys_str_mv AT setyaningsihwiwitaw ethanolicextractofcentellaasiaticatreatmentintheearlystageofhyperglycemiaconditioninhibitsglomerularinjuryandvascularremodelingindiabeticratmodel
AT arfiannur ethanolicextractofcentellaasiaticatreatmentintheearlystageofhyperglycemiaconditioninhibitsglomerularinjuryandvascularremodelingindiabeticratmodel
AT fitriawanakbars ethanolicextractofcentellaasiaticatreatmentintheearlystageofhyperglycemiaconditioninhibitsglomerularinjuryandvascularremodelingindiabeticratmodel
AT yuniartharatih ethanolicextractofcentellaasiaticatreatmentintheearlystageofhyperglycemiaconditioninhibitsglomerularinjuryandvascularremodelingindiabeticratmodel
AT saridwicr ethanolicextractofcentellaasiaticatreatmentintheearlystageofhyperglycemiaconditioninhibitsglomerularinjuryandvascularremodelingindiabeticratmodel